Gemcitabine + BCG clinical trials

A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.

This study looks at new ways to treat a type of bladder cancer called NMIBC. We want to find out if using special tests can help doctors choose the best treatment for each patient and see if treatments like BCG and Gemcitabine+BCG work better.